Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
For supported batches, BPC-157 research material is reviewed through a layered documentation model that may include source-lab analytical documentation, independent verification records where available, batch linkage, chromatogram data, report date, sample reference, and endotoxin-screening information
Cagrilintide Reconstitution Cagrilintide - dose per draw at common vial sizes Vial Size 5 mg BAC Water 2.0 mL Concentration 2.5 mg/mL 0.25 mg 0.10 mL (10 units) 0.5 mg 0.20 mL (20 units) 1.0 mg 0.40 mL (40 units) 2.4 mg 0.96 mL (96 units) Vial Size 10 mg BAC Water 2.0 mL Concentration 5.0 mg/mL 0.25 mg 0.05 mL (5 units) 0.5 mg 0.10 mL (10 units) 1.0 mg 0.20 mL (20 units) 2.4 mg 0.48 mL (48 units) Vial Size 10 mg BAC Water 1.0 mL Concentration 10.0 mg/mL 0.25 mg 0.025 mL (2.5 units) 0.5 mg 0.05 mL (5 units) 1.0 mg 0.10 mL (10 units) 2.4 mg 0.24 mL (24 units) Cagrilintide is sensitive - inject BAC water down the vial wall and swirl gently
It also helps regulate nitric oxide production, which plays a key role in reducing inflammation and supporting circulation to injured or stressed tissues
Consult the BPC-157 dosing guide for protocol details
GHK-Cu has systemic distribution, but local concentration near the injection site is higher
